A roadmap for how strategic forecasting can help you take your lab wins and convert them to market triumphs by prioritizing your clinical development opportunities and leaning in on your go-to-market strategy. At the intersection of science and commercial lies the keys to unlocking true asset value. This presentation will dive into how forecasting and market research helps us navigate this crucial overlap with confidence.
- Indication Prioritization – Understanding the therapeutic applications of the science and how to sequence them strategically for clinical development.
- LCM Strategy – Balancing odds across clinical, therapeutic, regulatory, and commercial dimensions, and factoring for environmental macros such as the IRA, etc.
- Financial Forecasting – Putting together a robust forecast story for validating investment theses, raising capital, seeking partnerships, etc. to drive the program ahead.
Monday September 30, 2024 12:15pm - 12:45pm EDT
Log in to leave feedback.
Feedback Submitted
